Hatchtech inks $279m head lice deal as VC market comes to life

Australian pharmaceutical company Hatchtech has inked a deal worth up to $279 million with Indian giant Dr. Reddy’s for the commercialisation of its innovative head lice treatment.

Learn More

Posted in — Sydney Morning Herald


chevron_leftPreviosly
OpenLearning and Smart Sparrow in edtech partnership
28 September 2015
Nextchevron_right
Emerging Systems to integrate Charm into EHS
30 July 2015

You may also like

08 August 2012

Virtual patient gets funding injection

Sydney Morning Herald

15 July 2012

Digital tools can reshape our methods

Sydney Morning Herald

12 June 2015

Venture capitalists target super fund members and SMSFs

Sydney Morning Herald

02 June 2021

No need for needle as COVID-19 vaccination patch shows promise

Sydney Morning Herald

08 August 2012

Garrett acts out NBN potential

Sydney Morning Herald

14 September 2015

Hatchtech inks $279m head lice deal as VC market comes to life

Sydney Morning Herald

View All

Ventured. Gained.

Subscribe to our Newsletter for the latest updates from 1V.

decor decor decor
decor decor decor decor decor
clear Close